You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | n/a | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Price / Revenue | n/a | n/a |
| Price / Book value | n/a |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (m) |
Pre-tax (m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|
| Four banks initiate coverage of Oxford Nanopore with positive ratings Sharecast News | 10 Nov |
|---|---|
| Oxford Nanopore ups revenue guidance after 'significant expansion' of UAE contract Sharecast News | 09 Nov |
| Oxford Nanopore surges after lifting revenue guidance Sharecast News | 15 Oct |
| Appointment of Senior Independent Director | 24-Jan-22 15:01 |
|---|---|
| Holding(s) in Company | 18-Jan-22 13:00 |
| Fastest human genome sequence uses Oxford Nanopore | 13-Jan-22 07:00 |
| Share Incentive Plan - Director/PDMR Shareholding | 11-Jan-22 18:00 |
| Update to FY21 revenue guidance | 07-Jan-22 12:00 |